Issued Patents All Time
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11407833 | Anti-VISTA antibody and use thereof | Youngae Lee, Sang Soon Byun, Jung-Min Ha, Sungho AHN, Keunhee Oh +4 more | 2022-08-09 |
| 11407834 | Anti-PD-L1 antibody and use thereof | Sungho AHN, Miju Park, Eun Hee Lee, Shin Ae Yi, Sang Soon Byun +5 more | 2022-08-09 |
| 10597457 | EGFRvIII antibody and composition comprising same | Jae Bong Yoon, Jinsang Yoo, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim +5 more | 2020-03-24 |
| 10155817 | Dual-target antibody targeting VEGFR-2 and DLL4 and pharmaceutical composition including same | Joong Kyu Kim, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim +19 more | 2018-12-18 |
| 10125194 | Dual targeting antibody of novel form, and use thereof | Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim | 2018-11-13 |
| 10106622 | Human antibody specific to c-Met and preparation method thereof | Jinsang Yoo, Ju Ryoung NAM, Sung Woo Kim, Weon Sup Lee, Sang Ryeol Shim +17 more | 2018-10-23 |
| 9963512 | Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same | Joong Kyu Kim, Sang Hoon Lee, Weon Sup Lee, Sung Woo Kim, Sang Ryeol Shim +19 more | 2018-05-08 |
| 9562227 | Method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5 | Semi Kim, Hee Kang, Myoung Suk Choi, Mi Ra LEE, Young Kyu Park | 2017-02-07 |
| 9249219 | Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof | Weon Sup Lee, Sang Ryeol Shim, Mi-Hee Park, Jeong-Eun Kang, Do-yun Kim +18 more | 2016-02-02 |
| 9249220 | Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof | Weon Sup Lee, Sang Ryeol Shim, Mi-Hee Park, Jeong-Eun Kang, Do-yun Kim +18 more | 2016-02-02 |
| 9150650 | Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof | Weon Sup Lee, Sang Ryeol Shim, Mi-Hee Park, Jeong-Eun Kang, Do-yun Kim +18 more | 2015-10-06 |